SMAD4 and exocrine pancreatic carcinoma: Recent studies have shown that SMAD4 inactivation is associated with the advanced disease state of various human tumors, including pancreatic carcinoma, esophageal carcinoma, colorectal carcinoma, renal cell carcinoma, as well as breast carcinoma [17-20].